Biotechnology Contract Manufacturing Market worth $24.8 bill

"In January 2023, WuXi Biologics entered into a licensing agreement with GSK plc for using WuXi Biologics' proprietary technology platforms. Under this, GSK was granted an exclusive global license for the research,

Related Keywords

United States , Japan , Wuxi , Jiangsu , China , American , America , Aashish Mehra , Boehringer Ingelheim International Gmbh Germany , Holdings Corporation Japan , Corporation Japan , Company Name , Catalent Inc , Abbvie Inc , Thermo Fisher Scientific Inc , Genscript Biotech Corporation , Research Private Ltd , Fujifilm , Wuxi Biologics , Wuxi Biologic , Contract Manufacturing Market , North America , North American , Sample Pages , Market Players , Thermo Fisher Scientific , Samsung Biologics , South Korea , Boehringer Ingelheim International Gmbh , Eurofins Scientific , Free Customization , Research Private , Release Distributed , Biotechnology Contract Manufacturing Market ,